Cohance Lifesciences Market Cap

Cohance Lifesciences has a market cap or net worth of 361.18 billion as of June 27, 2025. Its market cap has increased by 108.16% in one year.

Market Cap

361.18B

Enterprise Value

362.61B

Revenue

11.98B

Ranking

n/a

PE Ratio

90.34

Stock Price

944.10

Market Cap Chart

Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 361.18B, an increase of 1,071,496.61%. That is a compound annual growth rate of 475.17%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	361.18B	24.59%
Dec 31, 2024	289.89B	57.55%
Dec 29, 2023	184.00B	46.05%
Dec 30, 2022	125.98B	0.33%
Dec 31, 2021	125.56B	9.05%
Dec 31, 2020	115.14B	341,510.23%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,006.41B
Divi's Laboratories	1,748.51B
Cipla	1,222.71B
Apollo Hospitals Enterprise	1,012.53B
Zydus Lifesciences	988.07B
Mankind Pharma	952.91B
Aurobindo Pharma	650.61B
Fortis Healthcare	596.95B

Market Cap Rankings